T follicular helper cells in cancer DOI Creative Commons
Nicolás Gutiérrez-Melo, Dirk Baumjohann

Trends in cancer, Journal Year: 2023, Volume and Issue: 9(4), P. 309 - 325

Published: Jan. 14, 2023

T follicular helper (Tfh) cells provide essential help to B for effective antibody-mediated immune responses. Although the crucial function of these CD4+ in infection and vaccination is well established, their involvement cancer only beginning emerge. Increased numbers Tfh cell-derived or cell-associated malignancies are often associated with an unfavorable outcome, whereas various solid organ tumor types non-lymphocytic origin, presence frequently coincides a better prognosis. We discuss recent advances understanding how cell crosstalk CD8+ secondary tertiary lymphoid structures (TLS) enhances antitumor immunity, but may also exacerbate immune-related adverse events (irAEs) such as autoimmunity during checkpoint blockade (ICB) immunotherapy.

Language: Английский

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance DOI
Yanshuo Chu, Enyu Dai, Yating Li

et al.

Nature Medicine, Journal Year: 2023, Volume and Issue: 29(6), P. 1550 - 1562

Published: May 29, 2023

Language: Английский

Citations

200

The biology of TREM receptors DOI Open Access
Marco Colonna

Nature reviews. Immunology, Journal Year: 2023, Volume and Issue: 23(9), P. 580 - 594

Published: Feb. 7, 2023

Language: Английский

Citations

199

The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer DOI Creative Commons
Yutian Zou, Feng Ye, Yanan Kong

et al.

Advanced Science, Journal Year: 2022, Volume and Issue: 10(5)

Published: Dec. 18, 2022

Distant metastasis remains the major cause of morbidity for breast cancer. Individuals with liver or brain have an extremely poor prognosis and low response rates to anti-PD-1/L1 immune checkpoint therapy compared those at other sites. Therefore, it is urgent investigate underlying mechanism resistance develop more effective immunotherapy strategies these patients. Using single-cell RNA sequencing, a high-resolution map entire tumor ecosystem based on 44 473 cells from cancer metastases depicted. Identified by canonical markers confirmed multiplex immunofluorescent staining, metastatic features remarkable reprogramming immunosuppressive such as FOXP3+ regulatory T cells, LAMP3+ tolerogenic dendritic CCL18+ M2-like macrophages, RGS5+ cancer-associated fibroblasts, LGALS1+ microglial cells. In addition, PD-1 PD-L1/2 are barely expressed in CD8+ cancer/immune/stromal respectively. Interactions molecules LAG3-LGALS3 TIGIT-NECTIN2 between found play dominant roles escape. summary, this study dissects intratumoral heterogeneity microenvironment first time, providing insights into most appropriate

Language: Английский

Citations

183

A pan-cancer single-cell panorama of human natural killer cells DOI Creative Commons
Fei Tang, Jinhu Li, Lu Qi

et al.

Cell, Journal Year: 2023, Volume and Issue: 186(19), P. 4235 - 4251.e20

Published: Aug. 21, 2023

Natural killer (NK) cells play indispensable roles in innate immune responses against tumor progression. To depict their phenotypic and functional diversities the microenvironment, we perform integrative single-cell RNA sequencing analyses on NK from 716 patients with cancer, covering 24 cancer types. We observed heterogeneity cell composition a tumor-type-specific manner. Notably, have identified group of tumor-associated that are enriched tumors, show impaired anti-tumor functions, associated unfavorable prognosis resistance to immunotherapy. Specific myeloid subpopulations, particular LAMP3+ dendritic cells, appear mediate regulation immunity. Our study provides insights into NK-cell-based immunity highlights potential clinical utilities subsets as therapeutic targets.

Language: Английский

Citations

181

Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade DOI
Baolin Liu, Yuanyuan Zhang, Dongfang Wang

et al.

Nature Cancer, Journal Year: 2022, Volume and Issue: 3(9), P. 1123 - 1136

Published: Sept. 22, 2022

Language: Английский

Citations

177

Antibodies against endogenous retroviruses promote lung cancer immunotherapy DOI Creative Commons
Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield

et al.

Nature, Journal Year: 2023, Volume and Issue: 616(7957), P. 563 - 573

Published: April 12, 2023

Abstract B cells are frequently found in the margins of solid tumours as organized follicles ectopic lymphoid organs called tertiary structures (TLS) 1,2 . Although TLS have been to correlate with improved patient survival and response immune checkpoint blockade (ICB), underlying mechanisms this association remain elusive Here we investigate lung-resident cell responses patients from TRACERx 421 (Tracking Non-Small-Cell Lung Cancer Evolution Through Therapy) other lung cancer cohorts, a recently established immunogenic mouse model for adenocarcinoma 3 We find that both human adenocarcinomas elicit local germinal centre tumour-binding antibodies, further identify endogenous retrovirus (ERV) envelope glycoproteins dominant anti-tumour antibody target. ERV-targeting amplified by ICB humans mice, targeted inhibition KRAS(G12C) model. ERV-reactive antibodies exert activity extends model, ERV expression predicts outcome adenocarcinoma. Finally, effective immunotherapy requires CXCL13-dependent formation. Conversely, therapeutic CXCL13 treatment potentiates immunity synergizes ICB. Our findings provide possible mechanistic basis response.

Language: Английский

Citations

165

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine DOI Open Access
Xiujing He, Xiaowei Liu,

Fengli Zuo

et al.

Seminars in Cancer Biology, Journal Year: 2022, Volume and Issue: 88, P. 187 - 200

Published: Dec. 31, 2022

Language: Английский

Citations

164

Mechanisms driving the immunoregulatory function of cancer cells DOI
Antoinette van Weverwijk, Karin E. de Visser

Nature reviews. Cancer, Journal Year: 2023, Volume and Issue: 23(4), P. 193 - 215

Published: Jan. 30, 2023

Language: Английский

Citations

152

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer DOI
Jianxia Li, Cheng Wu, Huabin Hu

et al.

Cancer Cell, Journal Year: 2023, Volume and Issue: 41(6), P. 1152 - 1169.e7

Published: May 11, 2023

Language: Английский

Citations

146

‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses DOI Open Access
Dietmar Zehn, Robert Thimme, Enrico Lugli

et al.

Nature Immunology, Journal Year: 2022, Volume and Issue: 23(6), P. 836 - 847

Published: May 27, 2022

Language: Английский

Citations

126